5-HTP dosage for depression
Pro Research Analysisby 
Searched over 200M research papers
5-HTP Dosage for Depression: Clinical Evidence and Recommendations
Typical 5-HTP Dosages Used in Depression Studies
Research on 5-hydroxytryptophan (5-HTP) for depression has commonly used daily doses ranging from 150 mg to 300 mg, administered orally. In one study, depressed patients received either 150 mg or 300 mg per day, with some showing rapid and significant improvement in depressive symptoms . Another clinical trial used 150 mg per day for seven days, resulting in mild to moderate symptom improvement in about half of the participants 24. Additionally, studies have tested single doses of 200 mg, which were found to affect certain biological markers in patients with major depression .
5-HTP as an Augmentation Strategy
For individuals with depression resistant to standard treatments like SSRIs or SNRIs, 5-HTP has been studied as an add-on therapy. In one open-label study, women with treatment-resistant depression were given 100 mg of 5-HTP twice daily (totaling 200 mg per day) alongside creatine monohydrate for eight weeks. This combination led to a significant reduction in depression scores, with no serious side effects reported .
Over-the-Counter 5-HTP and Safety Considerations
5-HTP is available over the counter, typically in capsules containing 25 mg, 50 mg, or 100 mg. However, studies that found 5-HTP effective for depression generally used doses of 200 mg per day or higher, often with a peripheral decarboxylase inhibitor to reduce side effects and improve efficacy. Without such an inhibitor, higher doses may be needed, which could increase the risk of gastrointestinal side effects . Short-term use of 5-HTP appears to be safe, but there is limited evidence on long-term safety .
Source and Formulation of 5-HTP
5-HTP used in supplements is often extracted from the seeds of Griffonia simplicifolia, which naturally contain 5-HTP. Industrial extraction can yield capsules with 95–98% pure 5-HTP, and these have been shown to increase serotonin levels in the brain, supporting their use in depression 89.
Efficacy and Patient Response
Not all patients respond to 5-HTP. Studies indicate that those who do respond tend to have lower baseline serotonin levels, and non-responders may not metabolize 5-HTP efficiently 124. The therapeutic effect seems most pronounced in patients with serotonin deficiency .
Pharmacokinetic Challenges and Future Directions
One limitation of 5-HTP is its rapid metabolism, which can reduce its effectiveness. Slow-release formulations are being explored to maintain stable blood levels and potentially improve outcomes in treatment-resistant depression .
Conclusion
Clinical studies suggest that 5-HTP, at doses of 150–300 mg per day, may help alleviate depressive symptoms, especially in individuals with serotonin deficiency or those who have not responded to standard antidepressants. Doses of 200 mg per day or higher are commonly used in research, often with a peripheral decarboxylase inhibitor to enhance efficacy and reduce side effects. While short-term use appears safe, more research is needed to confirm long-term safety and optimal dosing strategies. Slow-release formulations may offer future benefits for treatment-resistant cases.
Sources and full results
Most relevant research papers on this topic